Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Medigene AG

MDG1
Current price
1.57 EUR 0 EUR (0.00%)
Last closed 1.64 EUR
ISIN DE000A1X3W00
Sector Healthcare
Industry Biotechnology
Exchange Berlin Exchange
Capitalization 27 451 738 EUR
Yield for 12 month -51.27 %
1Y
3Y
5Y
10Y
15Y
MDG1
21.11.2021 - 28.11.2021

Medigene AG, a biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer. The company's end-to-end platform enables the development of T cell receptor engineered T cell (TCR-T) therapies for multiple tumor indications. Its pipeline includes MDG1015, a TCR-T therapy product to treat multiple solid tumor indications; MDG10xx to treat multiple solid tumor; and MDG1011, a TCR-T immunotherapy candidate, which is in clinical development to treat blood cancer. It also focuses on dendritic cell vaccines. Medigene AG has a strategic partnership with BioNTech to develop TCRbased immunotherapies against cancer; and 2seventy bio, Inc. for the development of TCR immunotherapies, as well as a collaboration agreement with National Cancer Institute to evaluate the potential of T cell receptors to be used in new cell constructs for the treatment of solid tumors. It has operations in Germany, the United States, and Asia. The company has research collaboration with WuXi Biologics to design and co-research TCR-guided T Cell engagers (TCR-TCEs) for the treatment of difficult-to-treat tumors. Medigene AG was founded in 1994 and is headquartered in Munich, Germany. Address: Lochhamer Strasse 11, Munich, Germany, 82152

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.54 EUR

P/E ratio

Dividend Yield

Current Year

+6 023 349 EUR

Last Year

+31 191 844 EUR

Current Quarter

+1 454 428 EUR

Last Quarter

+2 234 050 EUR

Current Year

+2 975 738 EUR

Last Year

+29 212 345 EUR

Current Quarter

+1 122 016 EUR

Last Quarter

+1 848 232 EUR

Key Figures MDG1

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -14 754 909 EUR
Operating Margin TTM -281.19 %
PE Ratio
Return On Assets TTM -27.15 %
PEG Ratio
Return On Equity TTM -63.93 %
Wall Street Target Price 5.54 EUR
Revenue TTM 7 432 857 EUR
Book Value 1.33 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -6 %
Dividend Yield
Gross Profit TTM 29 212 345 EUR
Earnings per share -1.21 EUR
Diluted Eps TTM -1.21 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -213.98 %

Dividend Analytics MDG1

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History MDG1

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:2
Payout Ratio
Last Split Date 29.08.2024
Dividend Date

Stock Valuation MDG1

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.0883
Price Sales TTM 3.6933
Enterprise Value EBITDA 1.8128
Price Book MRQ 1.3748

Financials MDG1

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MDG1

For 52 weeks

1.6 EUR 5.5 EUR
50 Day MA 2.03 EUR
Shares Short Prior Month
200 Day MA 2.64 EUR
Short Ratio
Shares Short
Short Percent